Rhyme
fund manager
sector
B2B Services
geography
North America
Vintages
status
Portfolio
category
#Innovative

Rhyme

Co-invested company
Rhyme is the only real-time prior authorization network in the U.S., connecting healthcare providers and payers to accelerate decision-making and improve patient care. With Rhyme, the clinical effort required for prior authorizations was reduced by 91%, from 45 minutes to just 4 minutes, with 25% of authorizations requiring no human intervention.
Rhyme team, part of the Private Equity manager's portfolio Insight Partners

Rhyme key figures

+ 60
employees
187
partner hospitals
72 000
affiliated healthcare professionals
+ 160 M
final patient beneficiaries
Data at
4/10/24
*Source: Public data from company websites and social networks. For the most up-to-date information, we invite our investors to consult the reports available in their own space.

About Rhyme

Rhyme stands out as the only real-time prior authorization network in the U.S., offering a platform for direct liaison between healthcare providers and payers.

This platform integrates with providers' electronic health record systems and payers' case management systems, enabling real-time collaboration that accelerates decision-making and patient care.

Rhyme helps to significantly reduce the time and resources spent on the prior authorization process, which can have a major impact, accounting for up to 40-50% of a healthcare provider's revenue. This increased efficiency improves the care pathway for patients.

Thanks to Rhyme, clinical staff were able to reduce the effort spent on prior authorizations by 91%. A process that typically took 45 minutes was reduced to just 4 minutes, and 25% of prior authorizations required no human effort at all. Overall processing time for prior authorization requests was also reduced by 6.7 days.

In the same sector as Rhyme

Company videos
No items found.
Discover our exclusive services
Insight Partners
Odyssey 2021
Odyssey 2021
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio